오믹스 랩 서비스 시장 규모, 점유율, 동향 및 성장 분석 보고서(2026-2034년)

The Omics Lab Services Market size is expected to reach USD 341.74 Billion in 2034 from USD 103.52 Billion (2025) growing at a CAGR of 14.19% during 2026-2034.

The Global Omics Lab Services Market is expanding due to the increasing demand for genomics, proteomics, and metabolomics research. These services support advanced studies in personalized medicine, drug discovery, and disease diagnostics. Rising investments in life sciences research and the growing prevalence of chronic diseases are key factors driving market growth. Research institutions and pharmaceutical companies are increasingly outsourcing omics services to specialized laboratories.

Major growth drivers include technological advancements in sequencing technologies and bioinformatics tools. The decreasing cost of genomic sequencing has made omics research more accessible. Growing interest in precision medicine and targeted therapies is also fueling demand for comprehensive omics analysis. Additionally, government funding and collaborative research projects are encouraging the expansion of omics-based studies worldwide.

Looking forward, the market is expected to witness significant growth due to continuous innovation in multi-omics approaches. Integration of artificial intelligence and big data analytics will improve research efficiency and insights. Expansion of biotechnology and pharmaceutical industries in emerging economies will create new service opportunities. As personalized healthcare becomes more prominent, omics lab services will play a crucial role in shaping the future of medical research and treatment development.

Our reports are meticulously crafted to provide clients with comprehensive and actionable insights into various industries and markets. Each report encompasses several critical components to ensure a thorough understanding of the market landscape:

Market Overview: A detailed introduction to the market, including definitions, classifications, and an overview of the industry's current state.

Market Dynamics: In-depth analysis of key drivers, restraints, opportunities, and challenges influencing market growth. This section examines factors such as technological advancements, regulatory changes, and emerging trends.

Segmentation Analysis: Breakdown of the market into distinct segments based on criteria like product type, application, end-user, and geography. This analysis highlights the performance and potential of each segment.

Competitive Landscape: Comprehensive assessment of major market players, including their market share, product portfolio, strategic initiatives, and financial performance. This section provides insights into the competitive dynamics and key strategies adopted by leading companies.

Market Forecast: Projections of market size and growth trends over a specified period, based on historical data and current market conditions. This includes quantitative analyses and graphical representations to illustrate future market trajectories.

Regional Analysis: Evaluation of market performance across different geographical regions, identifying key markets and regional trends. This helps in understanding regional market dynamics and opportunities.

Emerging Trends and Opportunities: Identification of current and emerging market trends, technological innovations, and potential areas for investment. This section offers insights into future market developments and growth prospects.

MARKET SEGMENTATION

By Services

• Genomics
• Proteomics
• Transcriptomic
• Metabolomics
• Epigenetics

By End-Use

• Hardware Equipment (Instrument, Kits, Chips)
• Testing / Lab (Services)
• Analytics / Interpretation (Personalization and Interpretation)

By Product

• One-off
• Repeat
• Continuous

By Frequency of Service

• Hospitals
• Research Institutes
• Diagnostic Labs

By Business

• Cancer
• Pharmaco (Prescription, Non-Prescription)
• Reproductive
• Other Genetic Tests
• Forensics
• Population Studies
• Skincare
• Nutrition
• Vitamins and Supplements
• Genealogy
• Other Categories

COMPANIES PROFILED

• Agilent Technologies Inc, Beijing Genomics Institute BGI, Q2 Solutions, Spectrus, Flomics Biotech, PhenoSwitch Bioscience, Qiagen, Quest Diagnostics Incorporated, Thermo Fisher Scientific Inc
• We can customise the report as per your requirements.

TABLE OF CONTENTS

Chapter 1. PREFACE

• 1.1. Market Segmentation & Scope
• 1.2. Market Definition
• 1.3. Information Procurement
  • 1.3.1 Information Analysis
  • 1.3.2 Market Formulation & Data Visualization
  • 1.3.3 Data Validation & Publishing
• 1.4. Research Scope and Assumptions
  • 1.4.1 List of Data Sources

Chapter 2. EXECUTIVE SUMMARY

• 2.1. Market Snapshot
• 2.2. Segmental Outlook
• 2.3. Competitive Outlook

Chapter 3. MARKET VARIABLES, TRENDS, FRAMEWORK

• 3.1. Market Lineage Outlook
• 3.2. Penetration & Growth Prospect Mapping
• 3.3. Value Chain Analysis
• 3.4. Regulatory Framework
  • 3.4.1 Standards & Compliance
  • 3.4.2 Regulatory Impact Analysis
• 3.5. Market Dynamics
  • 3.5.1 Market Drivers
  • 3.5.2 Market Restraints
  • 3.5.3 Market Opportunities
  • 3.5.4 Market Challenges
• 3.6. Porter's Five Forces Analysis
• 3.7. PESTLE Analysis

Chapter 4. GLOBAL OMICS LAB SERVICES MARKET: BY SERVICES 2022-2034 (USD MN)

• 4.1. Market Analysis, Insights and Forecast Services
• 4.2. Genomics Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.3. Proteomics Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.4. Transcriptomic Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.5. Metabolomics Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.6. Epigenetics Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 5. GLOBAL OMICS LAB SERVICES MARKET: BY END-USE 2022-2034 (USD MN)

• 5.1. Market Analysis, Insights and Forecast End-use
• 5.2. Hardware Equipment (Instrument, Kits, Chips) Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.3. Testing / Lab (Services) Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.4. Analytics / Interpretation (Personalization and Interpretation) Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 6. GLOBAL OMICS LAB SERVICES MARKET: BY PRODUCT 2022-2034 (USD MN)

• 6.1. Market Analysis, Insights and Forecast Product
• 6.2. One-off Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 6.3. Repeat Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 6.4. Continuous Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 7. GLOBAL OMICS LAB SERVICES MARKET: BY FREQUENCY OF SERVICE 2022-2034 (USD MN)

• 7.1. Market Analysis, Insights and Forecast Frequency Of Service
• 7.2. Hospitals Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 7.3. Research Institutes Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 7.4. Diagnostic Labs Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 8. GLOBAL OMICS LAB SERVICES MARKET: BY BUSINESS 2022-2034 (USD MN)

• 8.1. Market Analysis, Insights and Forecast Business
• 8.2. Cancer Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 8.3. Pharmaco (Prescription, Non-Prescription) Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 8.4. Reproductive Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 8.5. Other Genetic Tests Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 8.6. Forensics Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 8.7. Population Studies Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 8.8. Skincare Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 8.9. Nutrition Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 8.10. Vitamins and Supplements Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 8.11. Genealogy Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 8.12. Other Categories Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 9. GLOBAL OMICS LAB SERVICES MARKET: BY REGION 2022-2034(USD MN)

• 9.1. Regional Outlook
• 9.2. North America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 9.2.1 By Services
  • 9.2.2 By End-use
  • 9.2.3 By Product
  • 9.2.4 By Frequency Of Service
  • 9.2.5 By Business
  • 9.2.6 United States
  • 9.2.7 Canada
  • 9.2.8 Mexico
• 9.3. Europe Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 9.3.1 By Services
  • 9.3.2 By End-use
  • 9.3.3 By Product
  • 9.3.4 By Frequency Of Service
  • 9.3.5 By Business
  • 9.3.6 United Kingdom
  • 9.3.7 France
  • 9.3.8 Germany
  • 9.3.9 Italy
  • 9.3.10 Russia
  • 9.3.11 Rest Of Europe
• 9.4. Asia-Pacific Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 9.4.1 By Services
  • 9.4.2 By End-use
  • 9.4.3 By Product
  • 9.4.4 By Frequency Of Service
  • 9.4.5 By Business
  • 9.4.6 India
  • 9.4.7 Japan
  • 9.4.8 South Korea
  • 9.4.9 Australia
  • 9.4.10 South East Asia
  • 9.4.11 Rest Of Asia Pacific
• 9.5. Latin America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 9.5.1 By Services
  • 9.5.2 By End-use
  • 9.5.3 By Product
  • 9.5.4 By Frequency Of Service
  • 9.5.5 By Business
  • 9.5.6 Brazil
  • 9.5.7 Argentina
  • 9.5.8 Peru
  • 9.5.9 Chile
  • 9.5.10 South East Asia
  • 9.5.11 Rest of Latin America
• 9.6. Middle East & Africa Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 9.6.1 By Services
  • 9.6.2 By End-use
  • 9.6.3 By Product
  • 9.6.4 By Frequency Of Service
  • 9.6.5 By Business
  • 9.6.6 Saudi Arabia
  • 9.6.7 UAE
  • 9.6.8 Israel
  • 9.6.9 South Africa
  • 9.6.10 Rest of the Middle East And Africa

Chapter 10. COMPETITIVE LANDSCAPE

• 10.1. Recent Developments
• 10.2. Company Categorization
• 10.3. Supply Chain & Channel Partners (based on availability)
• 10.4. Market Share & Positioning Analysis (based on availability)
• 10.5. Vendor Landscape (based on availability)
• 10.6. Strategy Mapping

Chapter 11. COMPANY PROFILES OF GLOBAL OMICS LAB SERVICES INDUSTRY

• 11.1. Top Companies Market Share Analysis
• 11.2. Company Profiles
  • 11.2.1 Agilent Technologies Inc
  • 11.2.2 Beijing Genomics Institute (BGI)
  • 11.2.3 Q2 Solutions
  • 11.2.4 Spectrus
  • 11.2.5 Flomics Biotech
  • 11.2.6 PhenoSwitch Bioscience
  • 11.2.7 Qiagen
  • 11.2.8 Quest Diagnostics Incorporated
  • 11.2.9 Thermo Fisher Scientific Inc